Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiology | 4 | 2023 | 1656 | 0.820 |
Why?
|
| Peripartum Period | 2 | 2024 | 137 | 0.790 |
Why?
|
| Acute Coronary Syndrome | 5 | 2019 | 2190 | 0.770 |
Why?
|
| Contraception | 1 | 2023 | 347 | 0.680 |
Why?
|
| Women | 1 | 2020 | 224 | 0.610 |
Why?
|
| Abortion, Induced | 1 | 2024 | 461 | 0.600 |
Why?
|
| Cardiovascular System | 1 | 2024 | 834 | 0.530 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2017 | 2745 | 0.520 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 161 | 0.510 |
Why?
|
| Pre-Eclampsia | 5 | 2024 | 1230 | 0.510 |
Why?
|
| Platelet Function Tests | 1 | 2017 | 271 | 0.490 |
Why?
|
| Physicians, Women | 2 | 2019 | 509 | 0.470 |
Why?
|
| Ticlopidine | 2 | 2017 | 730 | 0.460 |
Why?
|
| Career Choice | 2 | 2019 | 756 | 0.460 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 1948 | 0.450 |
Why?
|
| Heptanoic Acids | 1 | 2014 | 344 | 0.400 |
Why?
|
| Pravastatin | 1 | 2014 | 392 | 0.400 |
Why?
|
| Communication Barriers | 1 | 2014 | 414 | 0.370 |
Why?
|
| Graft Rejection | 1 | 2024 | 4446 | 0.370 |
Why?
|
| Adenosine | 1 | 2015 | 805 | 0.360 |
Why?
|
| Angina, Unstable | 1 | 2014 | 888 | 0.350 |
Why?
|
| Pregnancy | 15 | 2024 | 29868 | 0.350 |
Why?
|
| Sex Characteristics | 1 | 2019 | 2637 | 0.320 |
Why?
|
| Cardiovascular Agents | 1 | 2014 | 839 | 0.310 |
Why?
|
| Myocardial Infarction | 2 | 2023 | 11459 | 0.300 |
Why?
|
| Heparin | 1 | 2015 | 1632 | 0.300 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 491 | 0.300 |
Why?
|
| Pyrroles | 1 | 2014 | 1125 | 0.290 |
Why?
|
| Heart Failure | 6 | 2024 | 11669 | 0.280 |
Why?
|
| Blood Platelets | 1 | 2017 | 2478 | 0.260 |
Why?
|
| Aspirin | 1 | 2016 | 3127 | 0.240 |
Why?
|
| Societies, Medical | 1 | 2017 | 3900 | 0.240 |
Why?
|
| Ventricular Remodeling | 2 | 2023 | 1265 | 0.230 |
Why?
|
| Hemorrhage | 1 | 2015 | 3418 | 0.220 |
Why?
|
| Stroke Volume | 3 | 2023 | 5486 | 0.200 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 1924 | 0.190 |
Why?
|
| Sex Factors | 5 | 2024 | 10548 | 0.180 |
Why?
|
| Vascular Resistance | 1 | 2024 | 930 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 558 | 0.180 |
Why?
|
| Family Planning Services | 1 | 2023 | 266 | 0.180 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6403 | 0.180 |
Why?
|
| Female | 25 | 2024 | 392148 | 0.170 |
Why?
|
| Anticoagulants | 1 | 2015 | 4785 | 0.170 |
Why?
|
| Radiation Protection | 1 | 2023 | 424 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3608 | 0.160 |
Why?
|
| Menopause, Premature | 1 | 2020 | 124 | 0.160 |
Why?
|
| Live Birth | 1 | 2023 | 510 | 0.160 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3244 | 0.160 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2024 | 517 | 0.150 |
Why?
|
| Coronary Circulation | 1 | 2024 | 1569 | 0.150 |
Why?
|
| Pregnancy Trimester, First | 1 | 2022 | 908 | 0.150 |
Why?
|
| Personnel Selection | 1 | 2019 | 196 | 0.140 |
Why?
|
| Humans | 29 | 2024 | 760617 | 0.140 |
Why?
|
| Career Mobility | 1 | 2019 | 259 | 0.140 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 5031 | 0.140 |
Why?
|
| Echocardiography, Stress | 1 | 2017 | 134 | 0.140 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2019 | 857 | 0.130 |
Why?
|
| Counseling | 1 | 2023 | 1538 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 5776 | 0.120 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2018 | 576 | 0.120 |
Why?
|
| Platelet Aggregation | 1 | 2017 | 771 | 0.110 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2022 | 1723 | 0.110 |
Why?
|
| Job Satisfaction | 1 | 2017 | 544 | 0.100 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2018 | 829 | 0.100 |
Why?
|
| Cardiovascular Diseases | 3 | 2024 | 15498 | 0.100 |
Why?
|
| Menopause | 1 | 2020 | 1645 | 0.100 |
Why?
|
| Patient Participation | 1 | 2021 | 1443 | 0.100 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2018 | 696 | 0.100 |
Why?
|
| Neurons | 1 | 2010 | 9438 | 0.090 |
Why?
|
| Heart Ventricles | 2 | 2020 | 3796 | 0.090 |
Why?
|
| Heart Diseases | 1 | 2024 | 2778 | 0.090 |
Why?
|
| Aorta | 1 | 2018 | 2041 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 2024 | 3232 | 0.090 |
Why?
|
| Bromodeoxyuridine | 1 | 2010 | 310 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2016 | 1469 | 0.090 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 3873 | 0.090 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 239 | 0.080 |
Why?
|
| Premature Birth | 1 | 2022 | 1782 | 0.080 |
Why?
|
| Blood Coagulation | 1 | 2015 | 1154 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2016 | 1185 | 0.080 |
Why?
|
| Creatinine | 1 | 2014 | 1896 | 0.080 |
Why?
|
| Faculty, Medical | 1 | 2017 | 1204 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2015 | 4010 | 0.070 |
Why?
|
| Male | 10 | 2024 | 360358 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4845 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 7995 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2668 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2063 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 1670 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2022 | 22148 | 0.060 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2024 | 66 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 15828 | 0.050 |
Why?
|
| Risk Factors | 2 | 2023 | 74115 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 10199 | 0.050 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 1866 | 0.050 |
Why?
|
| Indoles | 1 | 2010 | 1830 | 0.050 |
Why?
|
| Prognosis | 1 | 2023 | 29600 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6224 | 0.050 |
Why?
|
| Parental Leave | 1 | 2022 | 93 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 15908 | 0.050 |
Why?
|
| Middle Aged | 6 | 2023 | 220584 | 0.040 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2024 | 324 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12334 | 0.040 |
Why?
|
| Incidence | 2 | 2018 | 21337 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2022 | 256 | 0.040 |
Why?
|
| Microvessels | 1 | 2024 | 577 | 0.040 |
Why?
|
| Laboratories | 1 | 2023 | 458 | 0.040 |
Why?
|
| Microcirculation | 1 | 2024 | 1272 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9529 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 12142 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 4408 | 0.040 |
Why?
|
| Catheterization | 1 | 2023 | 1428 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2024 | 1178 | 0.040 |
Why?
|
| Obesity | 1 | 2018 | 12933 | 0.030 |
Why?
|
| Adult | 4 | 2024 | 220969 | 0.030 |
Why?
|
| United States | 3 | 2022 | 72272 | 0.030 |
Why?
|
| Organ Size | 1 | 2020 | 2252 | 0.030 |
Why?
|
| Placenta | 1 | 2024 | 1709 | 0.030 |
Why?
|
| Rats | 1 | 2010 | 23717 | 0.030 |
Why?
|
| Age Factors | 1 | 2010 | 18381 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2020 | 1048 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 80566 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11514 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 12661 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2024 | 3095 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 1085 | 0.030 |
Why?
|
| Leadership | 1 | 2021 | 1385 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2018 | 1810 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 2921 | 0.020 |
Why?
|
| Mice | 2 | 2024 | 81368 | 0.020 |
Why?
|
| Triglycerides | 1 | 2018 | 2459 | 0.020 |
Why?
|
| Life Style | 1 | 2022 | 3904 | 0.020 |
Why?
|
| Animals | 3 | 2024 | 168201 | 0.020 |
Why?
|
| Cholesterol | 1 | 2018 | 2903 | 0.020 |
Why?
|
| Aortic Valve | 1 | 2018 | 1955 | 0.020 |
Why?
|
| Troponin T | 1 | 2013 | 780 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 6483 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5332 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2024 | 12116 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2018 | 3954 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2689 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2018 | 6390 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12447 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2022 | 26180 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2018 | 12943 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 169042 | 0.000 |
Why?
|
Concepts
(146)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(58)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_